Back to STATE STREET CORP STATE STREET CORP

CORTCORT

Showing 8 of 28 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in Corcept Therapeutics Incorporated.

Yes. State Street holds 3,279,381 shares of CORT (Corcept Therapeutics), worth $285.2M, as of its Q2 2026 13F filing. It increased the position by 78,435 shares (+2.5%) from Q1 2026. State Street has held CORT in every 13F on record since Q3 2019, 28 quarterly filings.

Current Value

$285.2M

Current Shares

3.3M

Total Value Change

+$122.3M

Total Shares Change

-239,882

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.3M
+2.5%
$285.2M0.0%$86.95
32
2026-Q1
Increased
3.2M
+7.2%
$129M0.0%$40.31
32
2025-Q4
Increased
3M
+0.5%
$103.9M0.0%$34.80
30
2025-Q3
Increased
3M
+0.1%
$246.9M0.0%$83.11
31
2025-Q2
Decreased
3M
-12.8%
$217.8M0.0%$73.40
0
2025-Q1
Decreased
3.4M
-4.1%
$388.6M0.0%$114.22
0
2024-Q4
Increased
3.5M
+0.8%
$178.8M0.0%$50.39
31
2024-Q3
Increased
3.5M
+0.6%
$162.9M0.0%$46.28
30

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used